- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 25 - Closing Remarks
As the panel discussion concludes, expert panelists share their final insights about the current US healthcare system and its initiatives to combat cardiovascular disease and cardiometabolic events.
David Calabrese, RPh, MHP, explains that although challenges exist they are not “insurmountable.” He believes that in order to overcome the current treatment barriers, a patient-centric approach is necessary when caring for patients.
Kenneth L. Schaecher, MD, FACP, CPC, and Yehuda Handelsman, MD, FACP, FACE, FNLA, agree that medicine is at an exciting era in the US, as new innovations provide additional tools to help coordinate care between clinicians and their patients. However, Dr Handelsman reminds that the US needs to develop programs that help pay for the expensive costs of healthcare.
Michael Weber, MD, concludes the discussion by defining preventive medicine and explains its importance when managing cardiometabolic conditions.
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
